Intraoperative online pachymetry important safety feature

Article

An initial clinical evaluation of the new ESIRIS excimer laser with integrated, online, optical coherence pachymetry (Schwind), showed that constant corneal monitoring is an important safety feature for LASIK procedures, Kumar J. Doctor said.

An initial clinical evaluation of the new ESIRIS excimer laser with integrated, online, optical coherence pachymetry (Schwind), showed that constant corneal monitoring is an important safety feature for LASIK procedures, Kumar J. Doctor said.

The study recruited 25 patients with myopia and myopic astigmatism. Optical pachymetry assessed corneal thickness and observed all eyes during all the steps of LASIK. The study used a 130 micron head for 46 eyes and 110 micron head for four eyes using the Carriazo Pendular microkeratome.

Attempted mean spherical equivalent refraction was 4.0 D (+/-3.0 D) and cylinder was, -1.0D (+/-0.50 D), with a mean calculated stromal depth of 80 (+/- 22) microns. Mean flap thickness was 115 (+/-15) microns and in every case achieved a residual corneal stroma of more than 250 microns. The immediate postoperative evaluation showed swelling of the cornea.

Pre- and postoperative central cornea thickness measurements showed a mean decrease from 503 microns (range: 431-599) to 423 (387-512) microns.

Dr Doctor of the Doctor Eye Institute, Mumbai, India, said safety required measurement of the flap thickness directly after the flap cut and it needed measurement of the ablation progress during LASIK treatment for a better control of the residual stromal thickness.

"This system of online pachymetry during LASIK is reproducible to the extent of 1 to 2 microns," said Dr Doctor. "Evaluation of residual corneal thickness is crucial to prevent corneal ectasia," he insisted, adding that the Schwind laser is a good and accurate system.

Ophthalmology Times Europe reporting from the XXIV Congress of the ESCRS, London, 9-13 September, 2006.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.